CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Single-Arm, Open-Label, Multicenter, Study of Folotyn® (Pralatrexate Injection) in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With Hematological Malignancies Including PTCL and CTCL

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02106650
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:30.638025+00:00
Published At: 2019-11-20T00:00:00+00:00
Record Updated At: 2019-11-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Relapsed Peripheral T-Cell Lymphoma", "Refractory Peripheral T-Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-11-20"
protocolSection.identificationModule.nctId: "NCT02106650"
protocolSection.identificationModule.officialTitle: "A Phase 2, Single-Arm, Open-Label, Multicenter, Study of Folotyn\u00ae (Pralatrexate Injection) in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With Hematological Malignancies Including PTCL and CTCL"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.